Sage Products, Inc.
10
0
0
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
10%
1 trials in Phase 3/4
56%
5 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections
Role: collaborator
Pre-operative Preparation Using 2% Chlorhexidine Cloth For Shoulder Surgery
Role: collaborator
2% Chlorhexidine Gluconate Skin Cloths to Prevent SSI in Spine Surgery Patients
Role: collaborator
Hand Hygiene and Hospital Acquired Infections
Role: collaborator
Cost-Effectiveness Study Comparing Chlorhexidine Bathing With Active Surveillance Cultures to Prevent Methicillin-resistant Staphylococcus Aureus & Other Hospital Infections
Role: collaborator
Study of Bathing With Chlorhexidine Impregnated Cloths on Nosocomial Infections in the Pediatric Intensive Care Unit
Role: collaborator
Eliminate Risk of Cardiac Surgical Site Events
Role: collaborator
MRSA Colonization and Control in the Dallas County Jail
Role: collaborator
Implementation and Evaluation of Revised Protocols for Oral Hygiene for Mechanically Ventilated Patients
Role: collaborator
Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections
Role: collaborator
All 10 trials loaded